找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Liver Cancer; Joseph C. Bottino,Richard W. Opfell,Franco M. Mugg Book 1985 Martinus Nijhoff Publishing, Boston 1985 adjuvant therapy.liver

[復(fù)制鏈接]
樓主: Dopamine
21#
發(fā)表于 2025-3-25 06:24:53 | 只看該作者
22#
發(fā)表于 2025-3-25 11:14:48 | 只看該作者
Chemotherapy of Liver Canceratment; regional infusion chemotherapy; combination or multidrug chemotherapy; and finally, the present resurgence of regional delivery systems with single or multiple agents. The chemotherapeutic agents employed as a common denominator throughout the chronology of liver tumor therapy have been the
23#
發(fā)表于 2025-3-25 13:17:44 | 只看該作者
New Chemotherapeutic Agents in Liver Canceruse of investigational approaches including resection, embolization, intra-arterial cytotoxic therapy, radiation, and a combination of these, as well as the trial of new and standard drugs or combination regimens by the systemic route. Pharmacologic studies are becoming more frequent and are essenti
24#
發(fā)表于 2025-3-25 19:31:52 | 只看該作者
Pharmacologic Studies of Hepatic Intra-Arterial Chemotherapyic effect [1]. Even when systemically administered (intravenous) chemotherapy is relatively ineffective, intra-arterial chemotherapy may still improve the likelihood of response by the generation of much greater drug exposures (defined by the concentration × time integral). Hepatic arterial chemothe
25#
發(fā)表于 2025-3-25 21:18:39 | 只看該作者
Regional Chemotherapy of Liver Cancerver metastases are found at autopsy in 41–75% of patients dying of cancer [2 and table 14–1]. Surgery offers the only possibility of cure [chapter 7]; but resection is possible in only 10–20% of primary and 5% of secondary liver cancers. Systemic chemotherapy has not consistently produced responses
26#
發(fā)表于 2025-3-26 03:01:59 | 只看該作者
Regional Arterial Therapy in the Management of Primary Liver Neoplasmsarterial chemotherapeutic agents had very little effect upon the survival of these patients despite tumor shrinkage [3,4]. An early report with doxorubicin, given intravenously as a single agent or in combination with other drugs, resulted in a response of 78% [5]. Later studies reported response ra
27#
發(fā)表于 2025-3-26 07:52:32 | 只看該作者
Joseph C. Bottino,Richard W. Opfell,Franco M. Mugg
28#
發(fā)表于 2025-3-26 11:35:24 | 只看該作者
29#
發(fā)表于 2025-3-26 13:31:38 | 只看該作者
Chusilp Charnsangavej,Sidney Wallace,C. Humberto Carrasco,William Bechtel
30#
發(fā)表于 2025-3-26 20:34:44 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 06:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
竹北市| 陇南市| 桃江县| 余江县| 大方县| 桐梓县| 罗田县| 廊坊市| 扎赉特旗| 大冶市| 侯马市| 九龙县| 集贤县| 惠来县| 大厂| 安溪县| 岐山县| 多伦县| 射洪县| 新宾| 信阳市| 襄垣县| 临湘市| 福贡县| 高州市| 册亨县| 昌黎县| 肥城市| 扶风县| 沧州市| 嘉鱼县| 天等县| 华阴市| 甘泉县| 花莲县| 凤城市| 普格县| 遵义县| 泸州市| 保靖县| 沙洋县|